XML 42 R33.htm IDEA: XBRL DOCUMENT
v3.21.1

Loans Receivable and Other Lending Investments, net (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2021
Receivables [Abstract] |
Schedule of the company's loans and other lending investments by class | The following is a summary of the Company's loans receivable and other lending investments by class ($ in thousands):
|  | As of
|  | March 31, 2021 |  | December 31, 2020
Construction loans |  |  |  |
Senior mortgages |  | $ | 277,253 |  |  | $ | 449,733 |
Corporate/Partnership loans |  | 20,623 |  |  | 65,100 |
Subtotal - gross carrying value of construction loans(1) |  | 297,876 |  |  | 514,833 |
Loans |  |  |  |
Senior mortgages |  | 49,758 |  |  | 35,922 |
Corporate/Partnership loans |  | 19,653 |  |  | 20,567 |
Subordinate mortgages |  | 11,839 |  |  | 11,640 |
Subtotal - gross carrying value of loans |  | 81,250 |  |  | 68,129 |
Other lending investments |  |  |  |
Financing receivables (refer to Note 5) |  | 47,409 |  |  | 46,549 |
Held-to-maturity debt securities |  | 92,196 |  |  | 90,715 |
Available-for-sale debt securities |  | 24,043 |  |  | 25,274 |
Subtotal - other lending investments |  | 163,648 |  |  | 162,538 |
Total gross carrying value of loans receivable and other lending investments |  | 542,774 |  |  | 745,500 |
Allowance for loan losses |  | (9,058) |  |  | (13,170) |
Total loans receivable and other lending investments, net |  | $ | 533,716 |  |  | $ | 732,330 |
____________________________________________________________ (1)As of March 31, 2021, 85%, or $254.4, gross carrying value of construction loans had completed construction.
Schedule of changes in the company's allowance for loan losses | Changes in the Company's allowance for loan losses were as follows for the three months ended March 31, 2021 ($ in thousands):
|  |  | General Allowance |  |  |  |
|  |  |  | Construction Loans |  | Loans |  | Held to Maturity Debt Securities |  | Financing Receivables |  | Specific Allowance |  | Total
Allowance for loan losses at beginning of period |  |  |  | $ | 6,541 |  |  | $ | 1,643 |  |  | $ | 3,093 |  |  | $ | 1,150 |  |  | $ | 743 |  |  | $ | 13,170 |
(Recovery of) provision for loan losses(1) |  |  |  | (3,648) |  |  | 172 |  |  | (408) |  |  | (152) |  |  | (76) |  |  | (4,112) |
Allowance for loan losses at end of period |  |  |  | $ | 2,893 |  |  | $ | 1,815 |  |  | $ | 2,685 |  |  | $ | 998 |  |  | $ | 667 |  |  | $ | 9,058 |
____________________________________________________________ (1)During the three months ended March 31, 2021, the Company recorded a recovery of loan losses of $3.8 million in its consolidated statement of operations due primarily to the repayment of loans during the three months ended March 31, 2021 and an improving macroeconomic forecast on commercial real estate markets since December 31, 2020. Of this amount, $0.3 million related to a provision for credit losses for unfunded loan commitments and is recorded as a reduction to "Accounts payable, accrued expenses and other liabilities." Changes in the Company's allowance for loan losses were as follows for the three months ended March 31, 2020 ($ in thousands):
|  |  | General Allowance |  |  |  |
|  |  |  | Construction Loans |  | Loans |  | Held to Maturity Debt Securities |  | Financing Receivables |  | Specific Allowance |  | Total
Allowance for loan losses at beginning of period |  |  |  | $ | 6,668 |  |  | $ | 265 |  |  | $ | — |  |  | $ | — |  |  | $ | 21,701 |  |  | $ | 28,634 |
Adoption of new accounting standard(1) |  |  |  | (353) |  |  | 98 |  |  | 20 |  |  | 964 |  |  | — |  |  | 729 |
Provision for loan losses(2) |  |  |  | 3,409 |  |  | 323 |  |  | 33 |  |  | 136 |  |  | — |  |  | 3,901 |
Allowance for loan losses at end of period |  |  |  | $ | 9,724 |  |  | $ | 686 |  |  | $ | 53 |  |  | $ | 1,100 |  |  | $ | 21,701 |  |  | $ | 33,264 |
____________________________________________________________ (1)On January 1, 2020, the Company recorded an increase to its allowance for loan losses of $3.3 million upon the adoption of ASU 2016-13, of which $2.5 million related to expected credit losses for unfunded loan commitments and was recorded in "Accounts payable, accrued expenses and other liabilities." (2)During the three months ended March 31, 2020, the Company recorded a provision for loan losses of $4.0 million due primarily to the adoption of ASU 2016-13, of which $0.1 million related to expected credit losses for unfunded loan commitments and was recorded as a reduction to "Accounts payable, accrued expenses and other liabilities."
Schedule of recorded investment in loans and associated allowance for loan losses | The Company's investment in loans and other lending investments and the associated allowance for loan losses were as follows as of March 31, 2021 and December 31, 2020 ($ in thousands):
| Individually Evaluated for Impairment(1) |  | Collectively Evaluated for Impairment |  | Total
As of March 31, 2021 |  |  |  |  |
Construction loans(2) | $ | 56,343 |  |  | $ | 241,533 |  |  | $ | 297,876 |
Loans(2) | — |  |  | 81,250 |  |  | 81,250 |
Financing receivables | — |  |  | 47,409 |  |  | 47,409 |
Held-to-maturity debt securities | — |  |  | 92,196 |  |  | 92,196 |
Available-for-sale debt securities(3) | — |  |  | 24,043 |  |  | 24,043 |
Less: Allowance for loan losses | (667) |  |  | (8,391) |  |  | (9,058) |
Total | $ | 55,676 |  |  | $ | 478,040 |  |  | $ | 533,716 |
As of December 31, 2020 |  |  |  |  |
Construction loans(2) | $ | 53,305 |  |  | $ | 461,528 |  |  | $ | 514,833 |
Loans(2) | — |  |  | 68,129 |  |  | 68,129 |
Financing receivables | — |  |  | 46,549 |  |  | 46,549 |
Held-to-maturity debt securities | — |  |  | 90,715 |  |  | 90,715 |
Available-for-sale debt securities(3) | — |  |  | 25,274 |  |  | 25,274 |
Less: Allowance for loan losses | (743) |  |  | (12,427) |  |  | (13,170) |
Total | $ | 52,562 |  |  | $ | 679,768 |  |  | $ | 732,330 |
_______________________________________________________________________________ (1)The carrying value of this loan includes an unamortized discount of $0.8 million and $0.8 million as of March 31, 2021 and December 31, 2020, respectively. The Company's loans individually evaluated for impairment represent loans on non-accrual status and the unamortized amounts associated with these loans are not currently being amortized into income. (2)The carrying value of these loans include unamortized discounts, premiums, deferred fees and costs totaling net discounts of $2.2 million and $2.3 million as of March 31, 2021 and December 31, 2020, respectively. (3)Available-for-sale debt securities are evaluated for impairment under ASC 326-30.
Schedule of investment in performing loans, presented by class and by credit quality, as indicated by risk rating | The Company's amortized cost basis in performing senior mortgages, corporate/partnership loans, subordinate mortgages and financing receivables, presented by year of origination and by credit quality, as indicated by risk rating, as of March 31, 2021 were as follows ($ in thousands):
|  | Year of Origination |  |  |
|  | 2021 |  | 2020 |  | 2019 |  | 2018 |  | 2017 |  | Prior to 2017 |  | Total |
Senior mortgages |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Risk rating |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
1.0 |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 75,014 |  |  | $ | — |  |  | $ | 75,014 |  |
1.5 |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |
2.0 |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |
2.5 |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |
3.0 |  | 33,419 |  |  | — |  |  | — |  |  | 113,154 |  |  | — |  |  | 3,714 |  |  | 150,287 |  |
3.5 |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |
4.0 |  | — |  |  | — |  |  | — |  |  | 45,366 |  |  | — |  |  | — |  |  | 45,366 |  |
4.5 |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |
5.0 |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |
Subtotal(1) |  | $ | 33,419 |  |  | $ | — |  |  | $ | — |  |  | $ | 158,520 |  |  | $ | 75,014 |  |  | $ | 3,714 |  |  | $ | 270,667 |  |
Corporate/partnership loans |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Risk rating |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
1.0 |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |
1.5 |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |
2.0 |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |
2.5 |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |
3.0 |  | 2,525 |  |  | — |  |  | — |  |  | 18,098 |  |  | — |  |  | — |  |  | 20,623 |  |
3.5 |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |
4.0 |  | — |  |  | — |  |  | — |  |  | 19,653 |  |  | — |  |  | — |  |  | 19,653 |  |
4.5 |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |
5.0 |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |
Subtotal |  | $ | 2,525 |  |  | $ | — |  |  | $ | — |  |  | $ | 37,751 |  |  | $ | — |  |  | $ | — |  |  | $ | 40,276 |  |
Subordinate mortgages |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Risk rating |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
1.0 |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |
1.5 |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |
2.0 |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |
2.5 |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |
3.0 |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 11,839 |  |  | 11,839 |  |
3.5 |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |
4.0 |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |
4.5 |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |
5.0 |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |
Subtotal |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 11,839 |  |  | $ | 11,839 |  |
Financing receivables |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Risk rating |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
1.0 |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |
1.5 |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |
2.0 |  | — |  |  | — |  |  | 47,409 |  |  | — |  |  | — |  |  | — |  |  | 47,409 |  |
2.5 |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |
3.0 |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |
3.5 |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |
4.0 |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |
4.5 |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |
5.0 |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |
Subtotal |  | $ | — |  |  | $ | — |  |  | $ | 47,409 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 47,409 |  |
Total |  | $ | 35,944 |  |  | $ | — |  |  | $ | 47,409 |  |  | $ | 196,271 |  |  | $ | 75,014 |  |  | $ | 15,553 |  |  | $ | 370,191 |  |
____________________________________________________________ (1)As of March 31, 2021, excludes $56.3 million for one loan on non-accrual status.
Schedule of recorded investment in loans, aged by payment status and presented by class | The Company's amortized cost basis in loans, aged by payment status and presented by class, was as follows ($ in thousands):
| Current |  | Less Than and Equal to 90 Days |  | Greater Than 90 Days |  | Total Past Due |  | Total
As of March 31, 2021 |  |  |  |  |  |  |  |  |
Senior mortgages | $ | 327,011 |  |  | $ | — |  |  | $ | — |  |  | — |  |  | $ | 327,011 |
Corporate/Partnership loans | 40,276 |  |  | — |  |  | — |  |  | — |  |  | 40,276 |
Subordinate mortgages | 11,839 |  |  | — |  |  | — |  |  | — |  |  | 11,839 |
Total | $ | 379,126 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 379,126 |
As of December 31, 2020 |  |  |  |  |  |  |  |  |
Senior mortgages | $ | 443,154 |  |  | $ | 42,501 |  |  | $ | — |  |  | $ | 42,501 |  |  | $ | 485,655 |
Corporate/Partnership loans | 42,721 |  |  | 42,946 |  |  | — |  |  | 42,946 |  |  | 85,667 |
Subordinate mortgages | 11,640 |  |  | — |  |  | — |  |  | — |  |  | 11,640 |
Total | $ | 497,515 |  |  | $ | 85,447 |  |  | $ | — |  |  | $ | 85,447 |  |  | $ | 582,962 |
Schedule of recorded investment in impaired loans | The Company's impaired loan was as follows ($ in thousands):
| As of March 31, 2021 |  | As of December 31, 2020
| Amortized Cost |  | Unpaid Principal Balance |  | Related Allowance |  | Amortized Cost |  | Unpaid Principal Balance |  | Related Allowance
With an allowance recorded: |  |  |  |  |  |  |  |  |  |  |
Senior mortgages(1) | $ | 56,343 |  |  | $ | 55,592 |  |  | $ | (667) |  |  | $ | 53,305 |  |  | $ | 52,552 |  |  | $ | (743) |
Total | $ | 56,343 |  |  | $ | 55,592 |  |  | $ | (667) |  |  | $ | 53,305 |  |  | $ | 52,552 |  |  | $ | (743) |
____________________________________________________________ (1)The Company has one non-accrual loan as of March 31, 2021 and December 31, 2020 that is considered impaired and included in the table above. The Company did not record any interest income on impaired loans for the three months ended March 31, 2021 and 2020.
Schedule of other lending investments - securities | Other lending investments includes the following securities ($ in thousands):
| Face Value |  | Amortized Cost Basis |  | Net Unrealized Gain |  | Estimated Fair Value |  | Net Carrying Value
As of March 31, 2021 |  |  |  |  |  |  |  |  |
Available-for-Sale Securities |  |  |  |  |  |  |  |  |
Municipal debt securities | $ | 20,480 |  |  | $ | 20,480 |  |  | $ | 3,563 |  |  | $ | 24,043 |  |  | $ | 24,043 |
Held-to-Maturity Securities |  |  |  |  |  |  |  |  |
Debt securities | 100,000 |  |  | 92,196 |  |  | — |  |  | 92,196 |  |  | 92,196 |
Total | $ | 120,480 |  |  | $ | 112,676 |  |  | $ | 3,563 |  |  | $ | 116,239 |  |  | $ | 116,239 |
As of December 31, 2020 |  |  |  |  |  |  |  |  |
Available-for-Sale Securities |  |  |  |  |  |  |  |  |
Municipal debt securities | $ | 20,680 |  |  | $ | 20,680 |  |  | $ | 4,594 |  |  | $ | 25,274 |  |  | $ | 25,274 |
Held-to-Maturity Securities |  |  |  |  |  |  |  |  |
Debt securities | 100,000 |  |  | 90,715 |  |  | — |  |  | 90,715 |  |  | 90,715 |
Total | $ | 120,680 |  |  | $ | 111,395 |  |  | $ | 4,594 |  |  | $ | 115,989 |  |  | $ | 115,989 |
Schedule of contractual maturities of securities | As of March 31, 2021, the contractual maturities of the Company's securities were as follows ($ in thousands):
| Held-to-Maturity Debt Securities |  | Available-for-Sale Debt Securities
| Amortized Cost Basis |  | Estimated Fair Value |  | Amortized Cost Basis |  | Estimated Fair Value
Maturities |  |  |  |  |  |  |
Within one year | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
After one year through 5 years | 92,196 |  |  | 92,196 |  |  | — |  |  | — |
After 5 years through 10 years | — |  |  | — |  |  | — |  |  | — |
After 10 years | — |  |  | — |  |  | 20,480 |  |  | 24,043 |
Total | $ | 92,196 |  |  | $ | 92,196 |  |  | $ | 20,480 |  |  | $ | 24,043 |

X
- Definition Tabular disclosure of the Company's recorded investment in loans and the associated reserve for loan losses. + References No definition available. + Details
Name: | star_ScheduleOfInvestmentInLoansAndAssociatedReserveForLoanLossesTableTextBlock
Namespace Prefix: | star_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of loans and other lending investments by class. Includes the gross carrying value of a loan by class, reserve for loan losses, and the net carrying value as of the Balance Sheet date. + References No definition available. + Details
Name: | star_ScheduleOfLoansAndOtherLendingInvestmentsTableTextBlock
Namespace Prefix: | star_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allowance for credit loss on financing receivable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section 50 -Paragraph 11B -URI http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 326 -SubTopic 20 -Section 50 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447 + Details
Name: | us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of financing receivables by credit quality indicator. The credit quality indicator is a statistic about the credit quality of financing receivables. Examples include, but not limited to, consumer credit risk scores, credit-rating-agency ratings, an entity's internal credit risk grades, loan-to-value ratios, collateral, collection experience and other internal metrics. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 326 -SubTopic 20 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section 50 -Paragraph 29 -URI http://asc.fasb.org/extlink&oid=121611835&loc=SL6953659-111524 + Details
Name: | us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of impaired financing receivables. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section 50 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=121611835&loc=d3e5212-111524 + Details
Name: | us-gaap_ImpairedFinancingReceivablesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments. + References No definition available. + Details
Name: | us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets. + References No definition available. + Details
Name: | us-gaap_MarketableSecuritiesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of aging analysis for financing receivable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 326 -SubTopic 20 -Section 50 -Paragraph 14 -URI http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section 50 -Paragraph 7A -URI http://asc.fasb.org/extlink&oid=121611835&loc=SL6953401-111524 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 326 -SubTopic 20 -Section 55 -Paragraph 80 -URI http://asc.fasb.org/extlink&oid=121647567&loc=SL82922355-210448 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section 50 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=121611835&loc=d3e5111-111524 + Details
Name: | us-gaap_PastDueFinancingReceivablesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ReceivablesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration